Received:
Monday, April 9, 2018
Commodity:
Radio Frequency Micro-Needle Dermatological Treatment Devices
Investigation Number:
Pending Institution
Filed By:
Smith R. Brittingham IV
Firm/Organization:
Finnegan, Henderson, Farabow, Garett, & Dunner LLP
Behalf Of:
Syneron Medical Ltd., Candela Corporation, and The General Hospital Corporation d/b/a Massachusetts General Hospital
Confidential:
Yes
Country:
None
Description:
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Radio Frequency Micro-Needle Dermatological Treatment Devices and Components Thereof. The proposed respondents are Invasix Inc., Irvine, CA; Invasix, Ltd., Israel; Inmode Md, Ltd., Irvine, CA; Ilooda Co., Ltd., Korea; Cutera, Inc., Brisbane, CA; Emvera Technologies LLC, Cedartown, GA; Rohrer Aesthetics, LLC, Homewood, AL; Lutronic, Corp., Korea; Lutronic, Inc., Burlington, MA; Endymed Medical Inc., New York, NY; Endymed Medical Ltd., Israel; Sung Hwan E&B Co., Ltd., Korea; Aesthetics Biomedical, Inc., Phoenix, AZ; Cartessa Aesthetics, Hockessin, DE; Jeisys Medical, Inc., Korea; Perigee Medical LLC, Tracy, CA; Lumenis Ltd., Israel; and Pollogen Ltd., Israel.
An official website of the United States government.